Gsk Plc Net Income per Employee (GSK), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Gsk Plc  (NYSE: GSK)
 

Gsk Plc Net Income per Employee

GSK's Quarterly Results, Trends, Rankings, Statistics
Gsk Plc's Income per employee grew in the third quarter 2026 on a trailing twelve month basis to $ 54,365,244, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees in only one company achieving higher income per employee than the Gsk Plc. While Gsk Plc's total ranking has deteriorated compared to the previous quarter from to 16.


What is Income per Employee Ratio?






GSK Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
0
III. Quarter
Y / Y Net Income Change - - - 181.14 % -
Net Income per Employee (TTM) $ 54,365,244 45,345,275 42,422,382 32,662,867 11,618,110
GSK's Total Ranking # 16 # # # # 33
Seq. Net Income Change 208.6 % -70.05 % -70.12 % - -


GSK Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 2
Overall Market # 16

Net Income per Employee Statistics
High Average Low
$ 76,083,003 $ 32,154,623 $ 14,849,528
(Dec 31 2022)   (Dec 31 2024)




  News about Gsk Plc Income per employee

GSK Investors Alert Navigating Class Action Lawsuits Amidst Shares Performance

In recent news concerning GlaxoSmithKline plc (GSK), Bronstein, Gewirtz and Grossman LLC has announced a new opportunity for investors who have suffered substantial losses in their GSK investments. The law firm is inviting affected shareholders to participate in a potential class action lawsuit, in response to regulatory and market pressures that have impacted the company’s stock performance.While the announcement of a class action lawsuit might raise concerns among investors, it s important to contextualize GSK s overall performance in the market. As of this month, GSK shares have experienced a slight downturn, with a performance rate of -2.67% compared to their peers and the broader market. Despite this recent dip, GSK’s year-to-date performance has shown resilience, as the company’s shares have outperformed the market overall.





Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Dariohealth Corp   48,073,963.64 $ 7,932.204  Million 165 


Date modified: 2026-11-19T03:16:03+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.